ClinicalTrials.govpublic full text
AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients
metastatic colorectal cancer, modified folfoxiri, cetuximab, avelumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803558
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.